Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Capsulin is an oral formulation of insulin designed for the management of diabetes mellitus. It is administered as a solid-dose capsule, typically taken twice daily before breakfast and dinner. Clinical studies have shown that Capsulin significantly reduces HbA1c, fasting plasma glucose (FPG), and triglyceride levels in patients with early-stage diabetes, without causing hypoglycemic events or significant weight gain. The primary mechanism of action is identical to that of traditional insulin therapy—regulation of blood glucose by facilitating cellular uptake and storage—but delivered via the gastrointestinal tract rather than injection. The product has been evaluated in phase 2b clinical trials for safety and efficacy[1][3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Capsulin.